title: Effective control of catatonia in Parkinson's disease by electroconvulsive therapy: a case report.
authors.forename: R
authors.initials: R
authors.lastname: Kamigaichi
authors.forename: S
authors.initials: S
authors.lastname: Kubo
authors.forename: K
authors.initials: K
authors.lastname: Ishikawa
authors.forename: K
authors.initials: K
authors.lastname: Yokoyama
authors.forename: K
authors.initials: K
authors.lastname: Ogaki
authors.forename: C
authors.initials: C
authors.lastname: Usui
authors.forename: K
authors.initials: K
authors.lastname: Hatta
authors.forename: H
authors.initials: H
authors.lastname: Arai
authors.forename: H
authors.initials: H
authors.lastname: Mochizuki
authors.forename: N
authors.initials: N
authors.lastname: Hattori
mesh_terms: D000368:Aged; D000978:Antiparkinson Agents / Q000008:administration & dosage; D001381:Azepines / Q000008:administration & dosage; D052160:Benzothiazoles / Q000008:administration & dosage; D000077465:Cabergoline; D002230:Carbidopa / Q000008:administration & dosage; D002389:Catatonia / Q000209:etiology / Q000628:therapy*; D002396:Catechols / Q000008:administration & dosage; D004359:Drug Therapy, Combination; D004565:Electroconvulsive Therapy; D004873:Ergolines / Q000008:administration & dosage; D005260:Female; D006801:Humans; D007980:Levodopa / Q000008:administration & dosage; D009570:Nitriles / Q000008:administration & dosage; D010300:Parkinson Disease / Q000150:complications / Q000503:physiopathology / Q000628:therapy*; D000077487:Pramipexole
chemical_list: D000978:Antiparkinson Agents; D001381:Azepines; D052160:Benzothiazoles; D002396:Catechols; D004873:Ergolines; D009570:Nitriles; D007980:Levodopa; C071192:entacapone; C024763:talipexole; D000077487:Pramipexole; D000077465:Cabergoline; D002230:Carbidopa